Locorten is developed by Novartis.

What development phase is Locorten in?

Locorten is FDA-approved (marketed).

What is the generic name of Locorten?

flumetasone pivalate is the generic (nonproprietary) name of Locorten.

Last reviewed 2026-05-14 · How we verify

Locorten (flumetasone pivalate)

Novartis · FDA-approved active Quality 10/100

At a glance

Generic name	flumetasone pivalate
Sponsor	Novartis
Drug class	flumetasone pivalate
Target	Glucocorticoid receptor
Therapeutic area	Immunology
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Locorten CI brief — competitive landscape report
Locorten updates RSS · CI watch RSS
Novartis portfolio CI